Back to today’s briefing

Story perspectives

FDA Approves Leucovorin for Autism; New Research Funded

9/24/2025

50 9 Full Breakdown

Summary

Story summary

The U.S. Food and Drug Administration (FDA) approved leucovorin for children with cerebral folate deficiency (CFD) and autism-like symptoms.
The Trump Administration issued a precautionary advisory to limit acetaminophen in pregnancy due to possible autism links, though unproven.
The National Institutes of Health (NIH) launched the Autism Data Science Initiative with over $50 million to advance autism research.

1 of 1

Story summary

The U.S. Food and Drug Administration (FDA) approved leucovorin for children with cerebral folate deficiency (CFD) and autism-like symptoms.
The Trump Administration issued a precautionary advisory to limit acetaminophen in pregnancy due to possible autism links, though unproven.
The National Institutes of Health (NIH) launched the Autism Data Science Initiative with over $50 million to advance autism research.